HHS Call for Input May Shed Light on Trump Administration's Vaccine Plans

The Department of Health and Human Services (HHS) has launched a request for public input regarding the framework of federal vaccine recommendations. This follows a contentious executive order which reduces the categories of universally recommended vaccines for children. The agency is evaluating whether to introduce additional or altered categories within the existing structure of routine, risk-based, and shared clinical decision-making recommendations.

The HHS inquiry seeks input on whether the current categories effectively convey the degree of evidence strength, individual and population benefits, and the scope for individual circumstances and personal values. It also explores the possibility that these categories might suggest that parental permission, individual consent, or thorough clinical discussions are solely applicable to the shared clinical decision-making recommendations.

HHS proposes augmenting the recommendation categories with new labels such as "recommended, but not during infancy," "recommended with qualification," and "shared clinical decision-making with qualification." The agency is also probing the potential advantages of shared clinical decision-making, including respecting autonomy, informed consent, religious beliefs, and personalized clinical judgment.

Conversely, it scrutinizes the risks of confusion, decreased access or acceptance, and time constraints in healthcare practices.

Richard Hughes IV, an attorney representing the American Academy of Pediatrics in its lawsuit against HHS, emphasized in an emailed statement that the HHS request for information, positioned as an open inquiry, is far from neutral. He noted that the creation of the shared clinical decision-making category was a result of years of deliberation by the CDC's Advisory Committee on Immunization Practices.

Hughes further warned that this move, disguised as a request for public input, demonstrates the administration's intent to alter existing recommendation categories, or even establish new ones.

The request for information also poses questions about the potential incorporation of recommendations from foreign agencies into U.S. guidance, a concept previously discussed by HHS Secretary Robert F. Kennedy Jr. in light of President Donald Trump's desire to align the U.S. childhood vaccine schedule with international standards.

It also proposes considerations for setting vaccine recommendations, such as the availability, quality, and robustness of evidence; the approach when randomized controlled trial evidence is unavailable, impractical, or unethical; disease severity and epidemiology; individual versus collective benefits; a preference for individual autonomy, informed consent, and religious liberty; and the feasibility and programmatic implications.

Lastly, HHS questions the implications of vaccine mandates and insights gleaned from vaccine communication strategies during the COVID-19 pandemic. The impact of the responses to this request for information remains uncertain. The deadline for submitting comments is set for September 20. Major medical organizations, including the Infectious Diseases Society of America, are expected to submit public comments.

The American Academy of Family Physicians (AAFP), in a letter to HHS, requested an extension of the comment period until October 23, citing the limited timeframe for stakeholders to respond.